https://www.indianpharmapost.com/alembic-pharmaceuticals-receives-5-usfda-product-approvals-in-q1-fy25-156222024-05-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbott-india-posts-q4-fy24-pat-at-rs-28706-cr-156232024-05-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/medico-remedies-posts-q4-fy24-pat-at-rs-309-cr-156242024-05-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/alembic-pharmaceuticals-posts-q4-fy24-pat-at-rs-17821-cr-156252024-05-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/cipla-receives-1-observation-from-usfda-for-kurkumbh-facility-156262024-05-10T00:00:00+05:30always0.9